Halozyme Reports Second Quarter 2017 Results
Go back to Halozyme Reports Second Quarter 2017 Results| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 109.68 +1.24 (1.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.44 | 52 Week High | $18.39 | |||
| Open | $107.08 | 52 Week Low | $6.96 | |||
| Day High | $110.88 | P/E | N/A | |||
| Day Low | $106.82 | EPS | $-0.58 | |||
| Volume | 1,983,629 | |||||

